Brian is internationally recognised for his research in the basic biology of ageing and as a visionary committed to translating research discoveries into new ways of delaying, detecting, and preventing human ageing and associated diseases. From 2010 to 2016 he was the President and CEO of the Buck Institute for Research on Aging. Currently he remains as a Professor at the institute. He also has an adjunct appointment at the USC Davis School of Gerontology. As well as being actively involved Biotechnology companies, serving in consulting and Board capacities, he also holds a position as Scientific Director of Affirmativ Health as well as Co-Editor-In-Chief at Aging Cell.